The University of Wisconsin School of Medicine and Public Health is a professional school for the study of medicine and public health at the University of Wisconsin–Madison. It is one of only two medical schools in Wisconsin, along with the Medical College of Wisconsin in Milwaukee, and the only public one.

During the past decade, University of Wisconsin School of Medicine and Public Health conducted 55 clinical trials. In the 10-year time frame, 55 clinical trials started and 29 clinical trials were completed, i.e. on average, 52.7% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 15 clinical trials were completed. i.e. 53.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Wisconsin School of Medicine and Public Health" #1 sponsor was "University of Wisconsin, Madison" with 40 trials, followed by "United Therapeutics" with 5 trials sponsored, "Pfizer" with 4 trials sponsored, "Shire" with 3 trials sponsored and "Abbott Medical Devices" with 3 trials sponsored. Other sponsors include 50 different institutions and companies that sponsored additional 52 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Wisconsin School of Medicine and Public Health" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 4 trials as a collaborator, "National Institutes of Health (NIH)" with 4 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 3 trials as a collaborator, "National Cancer Institute (NCI)" with 2 trials as a collaborator and "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 2 trials as a collaborator. Other collaborators include 63 different institutions and companies that were collaborators in the rest 68 trials.

According to Clinical.Site data, the most researched conditions in "University of Wisconsin School of Medicine and Public Health" are "Asthma" (5 trials), "Breast Cancer" (5 trials), "HIV Infections" (4 trials), "Pulmonary Hypertension" (4 trials) and "Chronic Obstructive Pulmonary Disease" (3 trials). Many other conditions were trialed in "University of Wisconsin School of Medicine and Public Health" in a lesser frequency.

Most popular intervention types in "University of Wisconsin School of Medicine and Public Health" are "Drug" (54 trials), "Device" (18 trials), "Other" (16 trials), "Biological" (10 trials) and "Behavioral" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "BinaxNOW Rapid Antigen System" (2 trials), "Clarithromycin" (2 trials), "Inhaled Treprostinil" (2 trials) and "Inhaled treprostinil solution" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Wisconsin School of Medicine and Public Health" are 95 trials for "All" genders, 12 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are 29 active trials in "University of Wisconsin School of Medicine and Public Health". 2 are not yet recruiting, 15 are recruiting, 10 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 65 completed trials in University of Wisconsin School of Medicine and Public Health, 1 suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in University of Wisconsin School of Medicine and Public Health, 6 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 30 trials that are defined as “Not Applicable".